IPOs/recent issues: Genomic Solutions –

Ann Arbor, Mich.

Went public on 5/5/2000 at $8 apiece

Filing Range: 7 mil. shares @ $10 to $12

Shares Outstanding: 22.7 mil. shares

Underwriters: UBS Warburg

Dain Rauscher Wessels/Lehman Brothers

Company Counsel:Jaffe, Raitt, Heuer & Weiss

Manager Counsel: Mintz Levin Cohn Ferris Glovsky & Popeo

Auditor: Arthur Andersen & Co.

The Company:

Designs, develops, manufactures, and markets integrated biochip and proteomic systems and services for analyzing and quantifying biomolecules, such as DNA, RNA, and proteins.

Venture Backers:

Chase Capital Partners

White Pines Management LLC

American Healthcare Fund

Capital Health Venture Partners

Sequel Venture Partners

Financing Rounds

Number of Round Amt.

Round # Round Date Stage Investors ($ thousands)

1 01/01/1997 2 Early Stage $150.0

2 10/01/1997 2 Expansion 6000.0

3 01/01/1998 4 Later Stage 7500.0

4 04/01/1998 2 Later Stage 6600.0

5 04/27/1999 4 Later Stage 6000.0

6 11/08/1999 6 Expansion 3490.0

7 02/01/2000 3 Expansion 8000.1

FINANCIALS

(Data in $ millions)

3 MOS.

03/31/00

Total Revenues: $13.7

Net Loss: -13.0